Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fondaparinux in Patients With Acute Heparin-Induced Thrombocytopenia

NCT00603824 is registered in ClinicalTrials.gov with Methodist Healthcare - Memphis as lead sponsor.

NCT NCT00603824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00603824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fondaparinux in Patients With Acute Heparin-Induced Thrombocytopenia
Lead sponsor
Methodist Healthcare - Memphis
Phase
Phase 4
Overall status
Withdrawn
Start date
January 31, 2008
Completion date
July 31, 2010
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

heparin-induced thrombocytopenia